National Press Club

FDA Commissioner Scott Gottlieb, MD, and Co-Chairs of the Congressional Cancer Survivors Caucus to Headline Upcoming NCCN Policy Summit

FDA Commissioner Scott Gottlieb, MD, and Co-Chairs of the Congressional Cancer Survivors Caucus to Headline Upcoming NCCN Policy Summit

June 25, 2018 9:30 AM

Location: Ballroom

Media Contact:
Rachel Darwin
267-622-6624 (w)
215-264-6232 (m)
darwin@nccn.org

FDA Commissioner Scott Gottlieb, MD, and Co-Chairs of the Congressional Cancer Survivors Caucus to Headline Upcoming NCCN Policy Summit

National Comprehensive Cancer Network is hosting a summit on Policy Strategies for the “New Normal” in Health Care to Ensure Access to High Quality Cancer Care in Washington, D.C. on June 25th.

What: NCCN Oncology Policy Summit: Policy Strategies for the “New Normal” in Health Care to Ensure Access to High Quality Cancer Care.

The summit will explore the impact of new innovations and the rapidly shifting health policy landscape on access to high-quality cancer care in the United States. Experts in the field will identify strategies to ensure access to and affordability of innovation and novel therapies, review current FDA policies intended to make oversight more effective and efficient, and discuss recent healthcare regulations and legislation and their real world implications for oncology.

When: Monday, June 25 ~ 9:30 AM– 3:15 PM
Where: The National Press Club – 13th Floor
529 14th Street NW
Washington, D.C.

Who: • Opening Keynote Speaker: Scott Gottlieb, MD, 23rd Commissioner of the FDA

• Closing Keynote Speakers: Congressman Mark DeSaulnier (D-CA), Congressman Ted Poe (R-TX)
Co-Chairs, Congressional Cancer Survivors Caucus, United States House of Representatives

• Welcome & Remarks: Robert W. Carlson, MD, NCCN CEO

• Moderator: Clifford Goodman, PhD, The Lewin Group

• Panelists Include: Joseph Alvarnas, MD, MS, City of Hope Comprehensive Cancer Center; Joe Antos, PhD, American Enterprise Institute; Jennifer Carlson, The Ohio State University Wexner Medical Center - James Cancer Hospital and Solove Research Institute; John Cox, DO, Parkland Health and Hospital System, UT Southwestern; Stephanie Farnia, MPH, The American Society for Blood and Marrow Transplantation; Elizabeth Franklin, LGSW, ACSW, Cancer Support Community; Anna Griffin, Kite, A Gilead Company; Meghan Gutierrez, Lymphoma Research Foundation; Caron A. Jacobson, MD, Dana Farber Cancer Institute/Brigham and Women’s Hospital; Stefanie Joho, Survivor, Health Advocate, and Consultant; Ron Kline, MD, FAAP, Center for Medicare and Medicaid Innovation (CMMI); Kavita Patel, MD, Brookings Institute; Pavan Reddy, MD, Kansas Society of Clinical Oncology, Cancer Center of Kansas; Alyssa Schatz, MSW, NCCN; Michael Ybarra, MD, PHrMA.

For more information and the full agenda, visit NCCN.org/policy. Join the conversation online with the hashtag #NCCNPolicy.

To request a complimentary press pass contact Rachel Darwin at darwin@nccn.org or (215) 264-6232.

About the National Comprehensive Cancer Network
The National Comprehensive Cancer Network® (NCCN®), a not-for-profit alliance of 27 leading cancer centers devoted to patient care, research, and education, is dedicated to improving the quality, effectiveness, and efficiency of cancer care so that patients can live better lives. Clinicians, visit NCCN.org. Patients and caregivers, visit NCCN.org/patients. Media, visit NCCN.org/news. Follow NCCN on Twitter @NCCNnews and Facebook @National.Comprehensive.Cancer.Network.

For More Information On This Event, Contact:

Rachel Darwin
267-622-6624
darwin@nccn.org